Position in DHR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$205,908
-$127,977 QoQ
Shares Held
1,081
-38.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,756
of 2,092 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORDEN GROUP LLC holds $3,533,170 across 7 Diagnostics & Research names. DHR ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
2,361 | $1,242,924 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,257 | $630,209 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,079 | $582,120 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
824 | $436,382 | |
| 5 | GH |
Guardant Health, Inc.
|
2,505 | $375,825 | |
| 6 | DHR |
Danaher Corp /De/
This page
|
1,081 | $205,908 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,788 | $59,802 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,908 | 1,081 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $333,885 | 1,761 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $385,959 | 1,686 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $292,631 | 1,476 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $256,011 | 1,296 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $259,120 | 1,264 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $355,343 | 1,548 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $425,370 | 1,530 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $265,340 | 1,062 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $276,190 | 1,106 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||